GenEdit

ParcelBio

This deep-tech firm develops mRNA delivery technologies and programmable medicines for biotechnology and pharmaceutical organisations to treat autoimmune diseases and oncology.

Rewrite Therapeutics

This deep-tech company develops DNA writing and genome editing tools for biotechnology firms to treat genetic diseases.

Granza Bio

This deep-tech company develops attack particle medicines to treat patients with cancer, autoimmune diseases and infections.

Nanite

Nanite develops programmable polymer nanoparticles for non-viral gene delivery to support genetic medicine companies and patient advocacy groups.

Nanograb

This company develops an artificial intelligence platform to design targeted gene delivery vectors and nanoparticles for pharmaceutical organisations developing genetic medicines.

Kodikaz Therapeutic Solutions

This deep-tech company develops a non-viral delivery platform for cell-specific gene therapies to treat cancer patients.

Immitra Bio

This company develops an in-vivo gene editing platform to provide off-the-shelf curative treatments for patients with rare genetic diseases.

Modulus Therapeutics

This company develops engineered NK-cell therapies for autoimmune disease patients using a generative design and rapid prototyping platform.